[Tumor-induction through cytostatic agents in man].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000139:chemically induced; D002066:Busulfan / Q000009:adverse effects; D002273:Carcinogens; D003520:Cyclophosphamide / Q000009:adverse effects; D006801:Humans; D007951:Leukemia, Myeloid / Q000139:chemically induced; D008175:Lung Neoplasms / Q000139:chemically induced; D008558:Melphalan / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D009369:Neoplasms / Q000139:chemically induced*; D010190:Pancreatic Neoplasms / Q000139:chemically induced; D012004:Rectal Neoplasms / Q000139:chemically induced; D014228:Triaziquone / Q000009:adverse effects; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced
D000970:Antineoplastic Agents; D002273:Carcinogens; D003520:Cyclophosphamide; D014228:Triaziquone; D002066:Busulfan; D008558:Melphalan; D008727:Methotrexate
Tumorinduktion durch Zytostatika beim Menschen